Peters, A. 2022. Emerging therapeutic agents in the treatment of relapsed or refractory diffuse large B cell lymphoma. Canadian Hematology Today. 1, 1 (Mar. 2022), 43–47. DOI:https://doi.org/10.58931/cht.2022.1110.